ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Clinical trial NCT00461266 · WITHDRAWN
Trial details
- NCT number
- NCT00461266
- Sponsor
- Hoffmann-La Roche
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2008-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.